scholarly journals Betegségismeret 2-es típusú diabetesszel élők körében: a Diabetes Knowledge Test magyar nyelvű validálása

2021 ◽  
Vol 162 (22) ◽  
pp. 870-877
Author(s):  
Orsolya Papp-Zipernovszky ◽  
Andrea Klinovszky ◽  
Norbert Buzás
Keyword(s):  
Blood Glucose ◽  
Health Literacy ◽  
Blood Glucose Level ◽  
Nutritional Value ◽  
Blood Glucose Measurement ◽  
Glucose Measurement ◽  
Diabetic Patients ◽  
Diabetes Knowledge ◽  
Knowledge Test ◽  
Illness Knowledge

Összefoglaló. Bevezetés: Magyarországon a KSH szerint több mint 1 millió ismert cukorbeteg él. A diabetes karbantartásához elengedhetetlen a betegek tudásának, készségeinek és önhatékonyságának növelése és fenntartása. A legelterjedtebb diabetes-betegségismeretteszt a 23 kérdéses Michigan Diabetes Knowledge Test. Első 14 tétele általános tudást mér, például az ételek tápanyagtartalmával és a vércukorszint-változás okaival kapcsolatban. További 9 kérdése az inzulinhasználatról szól. Célkitűzés: Célunk ennek a tesztnek a magyar nyelvű validálása, valamint összefüggéseinek vizsgálata szociodemográfiai és betegségváltozókkal. Módszer: Keresztmetszeti kérdőíves kutatásunkban a tesztcsomagot 129, inzulint használó, 2-es típusú diabeteses beteg töltötte ki (84 nő, átlagéletkor: 59,67; szórás: 12,6) elsősorban online, betegszervezeteken keresztül. Eredmények: A betegségismeret-teszt belső konzisztenciája 0,603, ami elfogadható érték. A 23 kérdés helyes kitöltési arányának átlaga 81,66%, ami az amerikai arányokhoz hasonló, más kutatások speciális csoportjaihoz képest azonban kifejezetten magas érték. A válaszadók a ketoacidosis fogalmát, az egyes ételek tápanyag-összetevőit és az elfogyasztott ételek vércukorszintre gyakorolt hatását illető kérdésekre tudták a választ a legkevésbé. A magyar teszt a szakirodalomnak megfelelő gyenge, negatív irányú összefüggésben áll az életkorral, és pozitív a kapcsolata az inzulinhasználat hosszával, valamint a napi vércukorszintmérés és inzulinbeadás számával. A betegségismeretet függetlenül egyedül a napi vércukorszintmérés mennyisége jósolta meg. A teszt konvergens validitását mutatja gyenge, de szignifikáns összefüggése az egészségértést mérő Brief Health Literacy Screening kérdésekkel. Következtetés: A magyar nyelvű Diabetes Betegségismeret Teszt alkalmas a diabetesszel élők tudásszintjének felmérésére. Mintánkban a betegségismeret magas szintje az inzulint használók megfelelő edukációjával függhet össze. Ugyanakkor eredményeink felhívják a figyelmet a betegek diétával kapcsolatos magasabb szintű tudásának szükségességére. Orv Hetil. 2021; 162(22): 870–877. Summary. Introduction: According to the Hungarian Central Statistical Office, more than 1 million diabetic patients live in Hungary. It is essential to enhance and sustain the knowledge, skills and self-efficacy of patients. The most widely used measurement of illness knowledge is the 23-item Michigan Diabetes Knowledge Test (DKT). Its first 14 items measure general knowledge: the nutritional value of food, and causes of change in blood glucose level. Its further 9 items are about insulin usage. Objective: To examine the reliability and the validity of the Hungarian version of DKT2 as well as its association with sociodemographic and illness-related variables. Methods: In our cross-sectional quantitative study, 129 patients (84 women, mean age: 59.67; SD = 12.6) diagnosed with type 2 diabetes mellitus using insulin therapy filled in a questionnaire online. Results: The α coefficient for the test is 0.603, which is acceptable. The mean of the correct answer rate is 81.66%, which resembles the American results, but it is higher than that of other specific groups. Problem areas for our patients included interpreting ketoacidosis, the nutritional value of foods and the effect of foods on blood glucose level. The score of the Hungarian test – in accordance with the literature – correlates negatively with age, positively with the year of insulin-usage and with the number of daily insulin intake and of blood glucose measurement. Illness knowledge was independently predicted only by the number of daily blood glucose measurement. The convergent validity of the Hungarian test is supported by its weak but significant association with Brief Health Literacy Screen questions. Conclusion: The Hungarian DKT2 properly measures the illness knowledge of diabetic patients. Their high level of knowledge can be traced back to the speciality of the subjects as well as to the overall education of insulin users. Nevertheless, our results draw attention to the necessity of enhancing the level of dietetic knowledge of patients. Orv Hetil. 2020; 162(22): 870–877.

EVALUATING THE UNCERTAINTY OF MEASUREMENT ON BLOOD'S GLUCOSE LEVEL

2005 ◽  
Vol 17 (02) ◽  
pp. 91-96 ◽  
Author(s):  
HUNG-CHUN HUANG ◽  
CHIA-HUNG CHIEN ◽  
CHENG-YI WANG ◽  
FOK-CHING CHONG
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Blood Glucose Measurement ◽  
University Hospital ◽  
Glucose Measurement ◽  
Clinical Test ◽  
Uncertainty Of Measurement ◽  
Continuous Increase ◽  
Iso 17025

Judging from the continuous increase in population suffering from chronic illnesses in the past 30 years in Taiwan, we can predict that the number of diabetes victims will reach 1.5 million in 15 years. This increase is global. According to an estimate provided by WTO, one out of two diabetes sufferers is not identified as the illness victim. An estimate of 100 million people in the world are diabetes patients. Although there is currently no way to completely cure diabetes, this disease can be controlled, monitored, and improved through education, research and development of new medication and techniques. However, the quality control of glucose monitoring has posed a stubborn problem to all fields related to the medical realm in Taiwan. By contrast, there is already a well-developed management system of blood glucose measurement in the West. All the standard-setting organizations, such as NCCLS and ISO, have published relevant Standard Operation Procedure (SOP). In Taiwan, we haven't had any similar certification mechanism. It is urgent for Taiwan to establish such standards specifically for the yellow race. Now, CNLA has introduced ISO 17025 in clinical test. Although it offers a general guideline, it doesn't specify detailed operation steps. As a result, it cannot offer an accurate result in blood glucose measurement. This paper is focused on ways to evaluate the uncertainty of measurement on blood glucose level based on the standard environment lab for medical device testing in the biomedical engineering department of National Taiwan University Hospital, so as to establish a function of uncertainty of measurement on blood glucose level and make it a stepping stone for certification of the measurement.

scholarly journals Non-Invasive Blood Glucose Measurement Technique for Diabetic Patients

2020 ◽  
Vol 9 (3) ◽  
pp. 4341-4345
Keyword(s):  
Blood Glucose ◽  
Near Infrared ◽  
Chemical Substance ◽  
Blood Glucose Measurement ◽  
Glucose Measurement ◽  
Diabetic Patients ◽  
Blood Samples ◽  
Non Invasive ◽  
Invasive Method ◽  
Precise Quantification

Diabetes mellitus is one of the most spreading diseases prevalent in the world. The Diabetic patients where in desideratum of monitoring their blood glucose level conventionally for a certain periodic of time. If they were nescient of their checkup it may lead to sundry symptoms like the feel profoundly slothful, tired etc. So they require for a periodic check up without fail. In clinic the prefer syringes for amassing the samples,in some worst cases there will be a possibility of unhydrated syringes . For checking they were in desideratum of a modicum of blood samples. For a precise quantification they will integrate some chemical substance to detect the value. While taking blood samples they feel so uncomfortable, pain and if the syringes where already used are not felicitously sterilized it may lead to sundry disease. The another method for quantifying the sample is a non-invasive. In non-invasive method there will be no desideratum of any syringe. It will be pain less and withal comfortable for the patients. In this paper we are introducing a non-invasive method in lieu of invasive method to be liberate from pain. Our proposed system consists of near infrared transmitter and receiver , a light dependent resistor etc,. The rays are sanctioned to passes through the finger it will quantify the glucose present in our cell and the output is given to the processor. The processed output will determine the quantity of glucose present in the blood . Then determinately the obtained output will be exhibited in the Liquid Crystal Exhibit.

scholarly journals Non-Invasive Blood Glucose Estimation using Handheld Near Infra-Red Device

2019 ◽  
Vol 8 (3S) ◽  
pp. 16-19 ◽  
Keyword(s):  
Blood Glucose ◽  
Near Infrared ◽  
Blood Glucose Measurement ◽  
Partial Least Square ◽  
Least Square ◽  
Blood Glucose Monitoring ◽  
Glucose Measurement ◽  
Coefficient Of Determination ◽  
Diabetic Patients ◽  
Non Invasive

Non-invasive blood glucose measurement would ease everyday life of diabetic patients and may cut the cost involved in their treatments. This project aims at developing a non-invasive blood glucose measurement using NIR (near infrared) spectroscopic device. NIR spectra data and blood glucose levels were collected from 45 participants, resulting 90 samples (75 samples for calibration and 15 samples for testing) in this project. These samples were then used to develop a predictive model using Interval Partial Least Square (IPLS) regression method. The results obtained from this project indicate that the handheld micro NIR has potential use for rapid non-invasive blood glucose monitoring. The coefficient of determination (R 2 ) obtained for calibration/training and testing dataset are respectively 0.9 and 0.91.

scholarly journals Effect of Poly-l-Lysine Polycation on the Glucose Oxidase/Ferricyanide Composite-Based Second-Generation Blood Glucose Sensors

Sensors ◽  
2019 ◽  
Vol 19 (6) ◽  
pp. 1448 ◽  
Author(s):  
Ming-Jie Lin ◽  
Ching-Chou Wu ◽  
Ko-Shing Chang
Keyword(s):  
Blood Glucose ◽  
Glucose Oxidase ◽  
Second Generation ◽  
Glucose Biosensor ◽  
Blood Glucose Measurement ◽  
Glucose Measurement ◽  
Diabetic Patients ◽  
Appreciable Effect ◽  
Serum Samples ◽  
Glucose Testing

Second-generation glucose biosensors are presently the mainstream commercial solution for blood glucose measurement of diabetic patients. Screen-printed carbon electrodes (SPCEs) are the most-used substrate for glucose testing strips. This study adopted hydrophilic and positively charged α-poly-l-lysine (αPLL) as the entrapment matrix for the immobilization of negatively charged glucose oxidase (GOx) and ferricyanide (FIC) on SPCEs to construct a disposable second-generation glucose biosensor. The αPLL modification is shown to facilitate the redox kinetics of FIC and ferrocyanide on the SPCEs. The SPCEs coated with 0.5 mM GOx, 99.5 mM FIC, and 5 mM αPLL had better sensitivity for glucose detection due to the appreciable effect of protonated αPLL on the promotion of electron transfer between GOx and FIC. Moreover, the SPCEs coated with 0.5 mM GOx, 99.5 mM FIC, and 5 mM αPLL were packaged as blood glucose testing strips for the measurement of glucose-containing human serum samples. The glucose testing strips had good linearity from 2.8 mM to 27.5 mM and a detection limit of 2.3 mM. Moreover, the 5 mM αPLL-based glucose testing strips had good long-term stability to maintain GOx activity in aging tests at 50 °C.

NON-INVASIVE BLOOD GLUCOSE ANALYSIS BASED ON GALVANIC SKIN RESPONSE FOR DIABETIC PATIENTS

2018 ◽  
Vol 30 (02) ◽  
pp. 1850009 ◽  
Author(s):  
U. Snekhalatha ◽  
T. Rajalakshmi ◽  
C. H. Vinitha Sri ◽  
G. Balachander ◽  
K. S. Shankar
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Galvanic Skin Response ◽  
Skin Resistance ◽  
Measurement Techniques ◽  
Glucose Measurement ◽  
Diabetic Patients ◽  
Non Invasive ◽  
Skin Response

Diabetes is a chronic disease due to the lack of production of hormone insulin by the beta cells in the islets of Langerhans. Many diabetic patients often draw a small amount of blood to measure the glucose level every day. This vital information is needed to control their daily food intake. One such method could cause infection and discomfort to the patient. Non-invasive glucose measurement techniques overcome these challenges to monitor blood glucose level continuously. The aim and objective of this study are as follows: (i) to correlate the skin resistance based on Galvanic skin response (GSR) and blood glucose level for diabetic and non-diabetic subject and (ii) to estimate the blood glucose value based on GSR voltage and resistance using stepwise linear regression model. About 50 diabetic and 50 non-diabetic subjects were included in this study. Blood glucose level is recorded using the minimally invasive device called accu-chek for all the subjects. GSR resistance and GSR voltage were recorded using the designed instrumentation setup. In diabetic subjects, the measured blood glucose level shows negative correlation with the GSR voltage ([Formula: see text], [Formula: see text]) and GSR resistance ([Formula: see text], [Formula: see text]). The estimated blood glucose level can be predicted with good sensitivity (94%) and accuracy (92%) using age and GSR voltage, or by the combination of age and GSR resistance in the evaluation of diabetic subjects.

scholarly journals Proposal of Blood Glucose Control and Exercise Therapy Support System Using Non-invasive Blood Glucose Meter

2020 ◽  
Vol 28 (S2) ◽  
Author(s):  
Ryo Takeuchi ◽  
Kazuhiko Nagao ◽  
Hiroyuki Miyamoto
Keyword(s):  
Blood Glucose ◽  
Exercise Therapy ◽  
Glucose Control ◽  
Blood Glucose Control ◽  
Blood Glucose Measurement ◽  
Glucose Measurement ◽  
Diabetic Patients ◽  
Non Invasive ◽  
Glucose Meter ◽  
Blood Glucose Meter

According to WHO, 420 million adults worldwide are suffering from diabetes. The diabetic patient should regularly verify and control their blood glucose levels. However, the existing blood glucose meters use a needle to collect blood, thus causing problems such as pain and infections. A non-invasive blood glucose meter is a measuring instrument that can avoid these problems, but such an instrument has not been developed to date. Diabetic patients should ensure blood glucose control and exercise therapy: however, the difficulty of management and lack of guidance on exercise therapy are problematic issues that need to be overcome. In this study, a non-invasive blood glucose meter and blood glucose control system has been developed, which can be used along with a healthcare sensor equipped with a non-invasive blood glucose measurement function.

scholarly journals Upper vs. lower extremity: Does the site of steroid injection have a different effect on blood glucose levels in patients with diabetes?

2020 ◽  
Vol 6 (2) ◽  
Author(s):  
Emilyn Anderi
Keyword(s):  
Blood Glucose ◽  
Steroid Injection ◽  
Clinical Decision ◽  
Blood Glucose Measurement ◽  
Glucose Measurement ◽  
Diabetic Patients ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Patients With Diabetes ◽  
Dose Injection

A clinical decision report appraising Twu J, Patel N, Wolf JM, Conti Mica M. Impact of variation of corticosteroid dose, injection site, and multiple injections on blood glucose measurement in diabetic patients. J Hand Surg Am. 2018;43(8):738-744. https://doi.org/10.1016/j.jhsa.2018.06.005 for a patient with diabetes and osteoarthritis.

scholarly journals Intraoperative Hyperglycemia May Be Associated with an Increased Risk of Myocardial Injury after Non-Cardiac Surgery in Diabetic Patients

2021 ◽  
Vol 10 (22) ◽  
pp. 5219
Author(s):  
Sojin Kim ◽  
Jungchan Park ◽  
Hara Kim ◽  
Kwangmo Yang ◽  
Jin-ho Choi ◽  
...  
Keyword(s):  
Cardiac Surgery ◽  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Myocardial Injury ◽  
Postoperative Mortality ◽  
Glucose Measurement ◽  
Diabetic Patients ◽  
Close Monitoring ◽  
Increased Risk

Background: Hyperglycemia in surgical candidates is associated with increased mortality and morbidity. We aimed to evaluate the effect of intraoperative blood glucose level on the incidence of myocardial injury after non-cardiac surgery (MINS) in diabetic patients. Methods: Diabetic patients with available intraoperative blood glucose measurement during non-cardiac surgery were enrolled in this study. Based on the highest intraoperative blood glucose level, patients were stratified into two groups: the blood sugar glucose (BST) < 180 group (intraoperative peak glucose < 180 mg/dL) and BST ≥ 180 group (intraoperative peak glucose ≥ 180 mg/dL). The primary outcome was the incidence of MINS, and secondary outcomes were in-hospital and 30-day mortalities. Results: Of the 11,302 diabetic patients, 8337 were in the BST < 180 group (73.8%) and 2965 in the BST ≥ 180 group (26.2%). After adjustment with inverse probability weighting, MINS was significantly higher in the BST ≥ 180 group (24.0% vs. 17.2%; odds ratio (OR), 1.26; 95% confidence interval (CI), 1.14–1.40; p < 0.001). In addition, in-hospital and 30-day mortalities were also higher in the BST ≥ 180 group compared to the BST < 180 group (4.2% vs. 2.3%, hazard ratio (HR), 1.39; 95% CI, 1.07–1.81; p = 0.001, and 3.1% vs. 1.8%; HR, 1.76; 95% CI, 1.31–2.36; p < 0.001, respectively). Receiver-operating characteristic plots showed that the threshold of glucose level associated with MINS was 149 mg/dL. Conclusion: Intraoperative hyperglycemia was associated with an increased MINS incidence and postoperative mortality in diabetic patients. Close monitoring of intraoperative blood glucose level may be helpful in detection and management of MINS.

scholarly journals HbA1c Is Not Potent Glucose Control Assessment Tool in Type 2 Diabetes Patients Treated With Insulin

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A470-A470
Author(s):  
Tzvetelina Totomirova ◽  
Mila Arnaudova
Keyword(s):  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Glucose Control ◽  
Assessment Tool ◽  
Blood Glucose Measurement ◽  
Glucose Measurement ◽  
Diabetic Patients ◽  
Premixed Insulin ◽  
Diabetes Patients

Abstract Glycated haemoglobin (HbA1c) is used for defining of glucose control in diabetic patients nevertheless its insufficiency to present overall control in some specific cases. Continuous Glucose Monitoring (CGM) is usually used for adjustment of insulin doses but the derived data are helpful for exact glucose control. We assess the potency of HbAc for defining of real glucose control in subgroup of type 2 diabetes patients treated with different insulin regimens. We studied 54 diabetic patients (33 men, 21 women; age 60.23±5.99 years, disease duration 12.64±5.02 years) - 33 with type 2 diabetes on pre-mixed insulin, 21 with type 2 on multiple insulin injection (MII). Patients performed multiple daily blood glucose measurements of fasting and prandial blood glucose for three months period. HbA1c was measured and CGM by using iProTM for seven days was performed at the end of this period. In pre-mixed insulin treated group and in intensified regimen group, moderate positive correlation was found between HbA1c and mean blood glucose derived from CGM (7.64±1.40% and 7.69±1.23%, respectively 7.64±1.48mmol/l and 7.60±1.30mmol/l), with r1=0.642 (p&lt;0.01) and r2=0.570 (p&lt;0.05). Even lower was correlation between HbA1c and time-in-range (r1=0.431 and r2 =0.401). There were no correlations between HbA1c and percentage of time spent below the target and number of hypoglycemic episodes in each group. Same trend of correlations was found comparing HbA1c and mean BG level in eight-point profile. Based on HbA1c assessment 36.36% of patients on premixed insulin, 19.05% of type 2 patients on MII were with good control. After estimation of results from SMBG these percentage were respectively 28.14% and 12.11%. CGM defined 27.27% of patients on premixed insulin, 13.80% of type 2 patients on MII as well controlled. We conclude that in insulin treated type 2 patients HbA1c gives relative information about overall control with no precise presenting of glucose fluctuations and out-of-range values of blood glucose with no information about hypoglycemic episodes. Nevertheless, short observed period CGM data could give much information that is comparable to three months blood glucose measurement and could replace the use of HbA1c for assessment of overall control. Reference: (1) Chehregosha H, et al. Diabetes Ther. 2019; 10, 853–863 (2) Beyond A1c Writing Group. Diab Care. 2018; 41: e92-e94 (3) Hirsch I et al. Diabetes Tech Ther 2017, 19 (3): S38-S48

Sign in / Sign up

Export Citation Format

Share Document